Anzeige
Mehr »
Login
Donnerstag, 25.04.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Wie die Revolution der sauberen Energie eine solide Investitionsmöglichkeit bieten könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
61 Leser
Artikel bewerten:
(0)

$1.23 Billion Insect Growth Regulators (IGRs) Market Analysis 2014-2025

DUBLIN, October 25, 2017 /PRNewswire/ --

The "Insect Growth Regulators (IGRs) Market Analysis, by Product (Chitin Synthesis Inhibitors, Juvenile Hormone Analogs & Mimics, Ecdysone Antagonists, Ecdysone Agonists), by Application, by Form and Segment Forecasts, 2014 - 2025" report has been added to Research and Markets' offering.

Research and Markets Logo

The global insect growth regulators (IGRs) market is expected to reach USD 1.23 billion by 2025

Globally increasing consumption of environment friendly pesticides has been a major factor driving market growth. In addition, growing adoption of organic farming techniques has led to the increased utilization of insect growth regulators.

IGRs are considered as a safer alternative to insecticides. These are non-toxic in nature and degrade rapidly. They also do not contaminate the groundwater and soil. The application of IGRs does not lead to harmful effects on advantageous soil microbes, animals, and humans. Numerous advantages of IGRs, such as lesser harmful impact on the environment and enhanced compatibility with pest management practices, make them attractive alternatives to several insecticides.

Juvenile hormone analogs and mimics were the fastest growing product category in 2016 and is expected to maintain a substantial growth rate over the forecast period. Chitin synthesis inhibitors was the major IGR consumed with a share of over 42% in 2016.

Commercial applications are expected to observe the fastest growth over the next eight years with an estimated CAGR of around 6.7% from 2016 to 2025. Commercial applications of IGRs include government pest control programs at public places, commercial office buildings, schools, hospitals, and aircrafts. Agriculture applications dominated the overall market in 2016. Farmers are adopting safer alternatives of harmful insecticides for application in farmlands and livestock. Moreover, increasing prevalence of organic farming and integrated pest management are posing huge demand towards demand of IGRs insect growth regulators in the global market.

Further key findings from the report suggest:



  • The global insect growth regulators revenue generated USD 723.3 million in 2016 and is expected to grow at a CAGR of 6.2% from 2017 to 2025
  • Chitin synthesis inhibitors emerged as the largest product segment in 2016
  • Global IGRs revenue from agriculture application is anticipated to witness staggered growth over the next eight years
  • The industry in Asia Pacific is projected to witness substantial growth over the next decade owing to various developments across major economies, especially in the agricultural industry.
  • Key players including Bayer AG, Central Life Science, OHP, Inc., Syngenta AG, Dow AgroSciences LLC, Helm Agro US, Inc., Nufarm Limited, Russell IPM, Valent USA LLC

Key Topics Covered:

Chapter 1 Methodology and Scope

Chapter 2 Executive Summary
2.1 Market snapshot

Chapter 3 Insect Growth Regulators Market Variables, Trends, and Scope
3.1 Market segmentation and scope
3.2 Penetration and growth prospect mapping
3.3 Value chain analysis
3.3.1 Raw Material Analysis
3.3.1.1 Methoprene
3.3.1.2 Hydroprene
3.3.1.3 Diflubenzuron
3.3.1.4 Pyriproxyfen
3.4 Regulatorsy framework
3.4.1 United States Environmental Protection Agency Registration
3.4.2 Europe Medicines Agency
3.4.3 WHO Guidelines
3.5 Insect growth regulators market dynamics
3.5.1 Market Driver Analysis
3.5.2 Increasing adoption of safer alternatives to insecticides
3.5.3 Rising applications in organic farming
3.5.4 Market restraint analysis
3.5.5 Slow process of action
3.6 Insect growth regulators market- Porter's analysis
3.7 Insect growth regulators market- PESTLE analysis

Chapter 4 Insect Growth Regulators Market: Product Estimates & Trend Analysis
4.1 Product movement analysis & market share, 2016 & 2025
4.2 Chitin synthesis inhibitors
4.3 Juvenile hormone agonists
4.4 Ecdysone Antagonists
4.5 Ecdysone Agonists

Chapter 5 Insect Growth Regulators Market: Form Estimates & Trend Analysis
5.1 Form movement analysis & market share, 2016 & 2025
5.2 Aerosol
5.3 Liquid
5.4 Bait

Chapter 6 Insect Growth Regulators Market: Application Estimates & Trend Analysis
6.1 Application movement analysis & market share, 2016 & 2025
6.2 Agriculture
6.3 Residential
6.4 Commercial

Chapter 7 Insect Growth Regulators Market: Regional Estimates & Trend Analysis

Chapter 8 Competitive Landscape

Chapter 9 Company Profiles

  • Bayer AG
  • Central Life Sciences
  • OHP, Inc.
  • Syngenta AG
  • Dow AgroSciences LLC
  • HELM AGRO US, Inc.
  • Nufarm Limited
  • Russell IPM
  • Valent U.S.A LLC
  • McLaughlin Gormley King Company
  • Sumitomo Chemical Company Limited
  • Control Solutions, Inc.

For more information about this report visit https://www.researchandmarkets.com/research/bgxb5r/insect_growth

Media Contact:


Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716



Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2017 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.